Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.370
+0.060 (1.39%)
At close: Aug 13, 2025, 4:00 PM
4.360
-0.010 (-0.23%)
After-hours: Aug 13, 2025, 4:06 PM EDT

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $258.22 million as of August 13, 2025. Its market cap has decreased by -28.21% in one year.

Market Cap
258.22M
Enterprise Value
-53.92M
1-Year Change
-28.21%
Ranking
Category
Stock Price
$4.37

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $258.22M, an increase of 23.26%. That is a compound annual growth rate of 1.09%.

History

DateMarket Cap% Change
Aug 12, 2025254.70M-8.81%
Dec 31, 2024279.30M15.03%
Dec 29, 2023242.80M-41.94%
Dec 30, 2022418.20M-52.16%
Dec 31, 2021874.10M21.64%
Dec 31, 2020718.60M-17.90%
Dec 31, 2019875.30M-36.13%
Dec 31, 20181.37B100.69%
Dec 29, 2017682.90M-2.57%
Dec 30, 2016700.90M75.84%
Dec 31, 2015398.60M-17.90%
Dec 31, 2014485.50M17.87%
Dec 31, 2013411.90M294.54%
Dec 31, 2012104.40M-21.97%
Dec 30, 2011133.80M-49.57%
Dec 31, 2010265.30M-13.30%
Dec 31, 2009306.00M2,200.75%
Dec 31, 200813.30M-92.75%
Dec 31, 2007183.40M-66.04%
Dec 29, 2006540.00M157.76%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 561.67B
Johnson & Johnson 417.44B
AbbVie 349.87B
Abbott Laboratories 233.71B
AstraZeneca 227.85B
UnitedHealth Group 227.59B
Novartis AG 225.61B
Novo Nordisk 224.34B
Market Cap Rankings